Home > Insider Trading > Filing (0001578259-14-000014)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
827809	Qlt Inc	QLTI	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1506916	A Jeffrey Meckler	C/O Qlt Inc. 887 Great Northern Way, Suite 250 Vancouver A1 V5T 4T5		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2014-12-18	20,000	$3.60	72,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares	Restricted Stock Unit	Acquisiton	2014-12-17	6,000	$0.00	6,000	$0.00
Common Shares	Stock option (right to buy)	Acquisiton	2014-12-17	12,500	$0.00	12,500	$3.51

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,000			No	4	A	Direct
12,500		2024-12-17	No	4	A	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.59 to $3.61, inclusive. The Reporting Person undertakes to provide to QLT Inc., any security holder of QLT Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer upon vesting.
The restricted stock units vest in three successive and equal yearly installments on the date of each of the first three annual general meetings of the Issuer held after December 17, 2014.
The restricted stock units have no fixed expiration date, but unvested units expire upon the Reporting Person's termination of service.
Option exercise price reflects the conversion of Canadian dollars to U.S. dollars based on the exchange rate in effect as of the date of grant. The option exercise price is CAD $4.08 per share, which was the closing price of the Issuer's common stock on the Toronto Stock Exchange as of the date of grant.
The options vest and become exercisable in thirty-six (36) successive and equal monthly installments beginning on the one-month anniversary of the date of grant (or January 17, 2015), such that 100% of the options will be fully vested on December 17, 2017.